![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Austin R M, Norris H J. Malignant Brenner tumour and transitional cell carcinoma of the ovary: a comparison. International Journal of Gynecological Pathology 1987; 6: 29–39
- Costa M J, Hansen C, Dickerman A, Scudder S A. Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumours (Stages 2 – 4). American Journal of Clinical Pathology 1998; 109: 173–180
- Gershenson D M, Silva E G, Mitchell M F, Atkinson E N, Wharton J T. Transitional cell carcinoma of the ovary: a matched control study of advanced stage patients treated with cisplatin-based chemotherapy. American Journal of Obstetrics and Gynecology 1993; 168: 1178–1187
- Gershenson D M, Baker V V, Price J E, Hung M -C, El-Naggar A K, Tortolero-Luna G, et al. Molecular profile of advanced-stage transitional cell carcinoma of the ovary. Obstetrics and Gynecology 1997; 177: 120–125
- Hussain S A, James N D. The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncology 2003; 4: 489–497
- Robey S S, Silva E G, Gershenson D M, McLemore D, El-Naggar A, Ordonez N G. Transitional cell carcinoma in high-grade, high-stage ovarian carcinoma. Cancer 1989; 63: 839–847
- Silva E G, Robey-Cafferty S S, Smith T L, Gershenson D M. Ovarian carcinoma with transitional cell carcinoma pattern. American Journal of Clinical Pathology 1990; 93: 457–465
- Sweeten K M, Gershenson D M, Burke T W, Morris M, Levenback C, Silva E G. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecologic Oncology 1995; 59: 211–215